Skip to main content

Exact Sciences to Participate in September Investor Conferences

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.

  • Wells Fargo Healthcare Conference, Boston

    Fireside chat on Wednesday, September 4, 2024 at 3:45 p.m. ET

  • Baird Global Healthcare Conference, New York

    Fireside chat on Wednesday, September 11, 2024 at 10:15 a.m. ET

The webcasts can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X (formerly known as Twitter) @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  228.85
+1.50 (0.66%)
AAPL  270.94
-2.73 (-1.00%)
AMD  214.84
+1.41 (0.66%)
BAC  55.98
+0.71 (1.29%)
GOOG  311.21
+2.60 (0.84%)
META  660.48
+1.71 (0.26%)
MSFT  484.95
-0.97 (-0.20%)
NVDA  183.36
+2.37 (1.31%)
ORCL  197.72
+5.75 (3.00%)
TSLA  488.20
+7.00 (1.45%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.